Yaz News: Bayer May Have Marketed Birth Control Pills for Unapproved Uses


In an online news article posted to Bloomberg’s website this week, it seems that pharmaceutical giant, Bayer AG, could have misled women regarding the potential health risks associated with use of their newer generation of birth control pills. According to information collected from the review of internal company e-mails, Bayer may have even sought to [...]

Eli Lilly Pulling Sepsis Drug Xigris


Following the results of a recent study which showed that Eli Lilly’s sepsis drug, Xigris, provided no better results in reducing mortality than that of a placebo, the pharmaceutical company announced it will pull the product from the market worldwide. Both The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have [...]

Drospirenone-Containing Birth Control Pills Still Under Scrutiny

Yaz Lawyer

In a new drug safety communication posted today on the U.S. Food and Drug Administration’s website, the agency announced that preliminary results of a study involving 800,000 women suggest a 1.5-fold increase in the risk of blood clots for those women using drospirenone-containing birth-control pills, compared to those taking other forms of hormonal contraceptives. Popular [...]

France’s Drug Safety Authority Suspends Use of Diabetes Drugs

actos | The Maher Law Firm

France’s drug authority announced on Thursday that it will suspend the use of two diabetes drugs, Actos and Competact, over concerns regarding cancer risks. The decision to issue the order for drug suspension came after the results of an official study conducted by the French Public Health Insurance Office revealed that the treatments were found [...]